MET-话题@MedSci

#MET#

1464篇内容 | 3155人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1896730, encodeId=4d0f1896e30a2, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Cell Metab：天下武功，唯快不破！傅肃能组揭示果糖有“毒”的秘密, objectType=article, longId=199766, objectId=21ec199e660f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21ec199e660f, replyNumber=0, likeNumber=84, createdTime=2021-05-04, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21ec199e660f, moduleTitle=Cell Metab：天下武功，唯快不破！傅肃能组揭示果糖有“毒”的秘密, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21ec199e660f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896769, encodeId=6a1f1896e6978, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Nat Metab：“神药”还是“毒药”，二甲双胍缩短衰老生物体寿命, objectType=article, longId=202891, objectId=5d1c20289190, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d1c20289190, replyNumber=0, likeNumber=84, createdTime=2021-01-20, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d1c20289190, moduleTitle=Nat Metab：“神药”还是“毒药”，二甲双胍缩短衰老生物体寿命, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d1c20289190)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896646, encodeId=226d189664684, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=AACR 2020：伯瑞替尼治疗MET异常NSCLC，ORR达30.5%, objectType=article, longId=193168, objectId=64ac1931686b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64ac1931686b, replyNumber=0, likeNumber=62, createdTime=2021-01-22, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64ac1931686b, moduleTitle=AACR 2020：伯瑞替尼治疗MET异常NSCLC，ORR达30.5%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64ac1931686b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896664, encodeId=1def18966647f, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Diabetes Obes Metab：2型糖尿病患者DPP-4抑制剂治疗与COVID-19, objectType=article, longId=194932, objectId=a64319493248, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a64319493248, replyNumber=0, likeNumber=71, createdTime=2020-06-27, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a64319493248, moduleTitle=Diabetes Obes Metab：2型糖尿病患者DPP-4抑制剂治疗与COVID-19, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a64319493248)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896761, encodeId=bd941896e61a3, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=JNNP:抗Aβ药物治疗轻中度阿尔茨海默病的系统回顾和meta分析, objectType=article, longId=202222, objectId=d76520222207, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d76520222207, replyNumber=0, likeNumber=67, createdTime=2020-11-25, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d76520222207, moduleTitle=JNNP:抗Aβ药物治疗轻中度阿尔茨海默病的系统回顾和meta分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d76520222207)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896729, encodeId=59cb1896e29c9, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Trends Endocrinol Metab：重新思考胰岛素与癌症的关系, objectType=article, longId=199679, objectId=38401996e948, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38401996e948, replyNumber=0, likeNumber=101, createdTime=2020-09-20, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38401996e948, moduleTitle=Trends Endocrinol Metab：重新思考胰岛素与癌症的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38401996e948)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896623, encodeId=eb38189662329, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=日本批准CABOMETYX（cabozantinib）治疗无法切除的或转移性肾细胞癌, objectType=article, longId=190852, objectId=502a190852b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=502a190852b7, replyNumber=0, likeNumber=51, createdTime=2020-09-29, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=502a190852b7, moduleTitle=日本批准CABOMETYX（cabozantinib）治疗无法切除的或转移性肾细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=502a190852b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896792, encodeId=b0f41896e928b, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Cell Metabolism：人类能否战胜糖尿病？这方面可能要向猪学学了！, objectType=article, longId=204863, objectId=580a204863e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=580a204863e6, replyNumber=0, likeNumber=69, createdTime=2021-12-02, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=580a204863e6, moduleTitle=Cell Metabolism：人类能否战胜糖尿病？这方面可能要向猪学学了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=580a204863e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896738, encodeId=1c221896e38c3, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=NEJM：Tepotinib治疗MET外显子14跳跃突变非小细胞肺癌II期临床效果显著, objectType=article, longId=200217, objectId=5dcd20021e20, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5dcd20021e20, replyNumber=0, likeNumber=69, createdTime=2020-09-12, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5dcd20021e20, moduleTitle=NEJM：Tepotinib治疗MET外显子14跳跃突变非小细胞肺癌II期临床效果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5dcd20021e20)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896798, encodeId=60a31896e9866, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Cell Metab :全世界都在“抗糖”，看看Cell子刊怎么说, objectType=article, longId=205316, objectId=6a4420531632, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a4420531632, replyNumber=0, likeNumber=87, createdTime=2021-04-03, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a4420531632, moduleTitle=Cell Metab :全世界都在“抗糖”，看看Cell子刊怎么说, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a4420531632)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896759, encodeId=b7d11896e59d1, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Diabetes Obes Metab：2型糖尿病患者肥胖与严重COVID-19结局之间的关系, objectType=article, longId=202196, objectId=2c9620219652, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c9620219652, replyNumber=0, likeNumber=62, createdTime=2020-10-30, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c9620219652, moduleTitle=Diabetes Obes Metab：2型糖尿病患者肥胖与严重COVID-19结局之间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c9620219652)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896634, encodeId=c5011896634cc, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Diabetes Obes Metab：血糖控制与主要心血管事件减少之间的关系, objectType=article, longId=191709, objectId=aac2191e090d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aac2191e090d, replyNumber=0, likeNumber=70, createdTime=2020-05-23, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aac2191e090d, moduleTitle=Diabetes Obes Metab：血糖控制与主要心血管事件减少之间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aac2191e090d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896777, encodeId=06701896e77b0, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Metabolism：MAFLD与CKD风险, objectType=article, longId=203498, objectId=4905203498a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4905203498a9, replyNumber=0, likeNumber=72, createdTime=2021-04-11, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4905203498a9, moduleTitle=Metabolism：MAFLD与CKD风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4905203498a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896722, encodeId=e6f21896e22d2, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Diabetes Obes Metab：清除慢性丙型肝炎病毒感染可降低2型糖尿病发生率, objectType=article, longId=198925, objectId=36aa198925be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36aa198925be, replyNumber=0, likeNumber=57, createdTime=2021-03-10, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36aa198925be, moduleTitle=Diabetes Obes Metab：清除慢性丙型肝炎病毒感染可降低2型糖尿病发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36aa198925be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896750, encodeId=eed91896e50b5, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Clin Cancer Res：转移性去势抵抗性前列腺癌c-MET和雄激素受体双重阻断:恩扎鲁胺和克唑替尼联合应用的一期研究, objectType=article, longId=201364, objectId=cf922013647f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf922013647f, replyNumber=0, likeNumber=79, createdTime=2021-05-19, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf922013647f, moduleTitle=Clin Cancer Res：转移性去势抵抗性前列腺癌c-MET和雄激素受体双重阻断:恩扎鲁胺和克唑替尼联合应用的一期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf922013647f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896779, encodeId=8eba1896e7916, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Metabolism：心外膜脂肪组织与COVID-19患者肺炎严重程度和不良结局相关, objectType=article, longId=203607, objectId=7b4520360e3c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b4520360e3c, replyNumber=0, likeNumber=83, createdTime=2021-05-06, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b4520360e3c, moduleTitle=Metabolism：心外膜脂肪组织与COVID-19患者肺炎严重程度和不良结局相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b4520360e3c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896598, encodeId=f7b21896598aa, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=TAZVERIK（Tazemetostat）已获批准用于治疗上皮样肉瘤, objectType=article, longId=186735, objectId=a745186e35dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a745186e35dc, replyNumber=0, likeNumber=62, createdTime=2020-02-11, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a745186e35dc, moduleTitle=TAZVERIK（Tazemetostat）已获批准用于治疗上皮样肉瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a745186e35dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896709, encodeId=303d1896e098d, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=LSALT肽（Metablok）治疗COVID-19：II期临床试验将在美国进行, objectType=article, longId=198327, objectId=861219832eff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=861219832eff, replyNumber=0, likeNumber=47, createdTime=2020-10-06, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=861219832eff, moduleTitle=LSALT肽（Metablok）治疗COVID-19：II期临床试验将在美国进行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=861219832eff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896641, encodeId=fe3f189664140, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Metabolism：肥胖是代谢相关脂肪肝患者发生更严重COVID-19的危险因素, objectType=article, longId=192606, objectId=06b4192606c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06b4192606c8, replyNumber=0, likeNumber=61, createdTime=2021-02-03, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06b4192606c8, moduleTitle=Metabolism：肥胖是代谢相关脂肪肝患者发生更严重COVID-19的危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06b4192606c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896685, encodeId=ca61189668552, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=J Clin Endocrinol Metab：长期地诺单抗治疗可降低骨质疏松相关的非椎骨骨折风险, objectType=article, longId=196655, objectId=efee19665592, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efee19665592, replyNumber=0, likeNumber=73, createdTime=2020-09-10, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efee19665592, moduleTitle=J Clin Endocrinol Metab：长期地诺单抗治疗可降低骨质疏松相关的非椎骨骨折风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=efee19665592)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

MET

2020-05-29

一闲 (审核中...)

前往app查看评论内容

#MET#

Cell Metab：天下武功，唯快不破！傅肃能组揭示果糖有“毒”的秘密

2021-05-04

一闲 (审核中...)

前往app查看评论内容

#MET#

Nat Metab：“神药”还是“毒药”，二甲双胍缩短衰老生物体寿命

2021-01-20

一闲 (审核中...)

前往app查看评论内容

#MET#

AACR 2020：伯瑞替尼治疗MET异常NSCLC，ORR达30.5%

2021-01-22

一闲 (审核中...)

前往app查看评论内容

#MET#

Diabetes Obes Metab：2型糖尿病患者DPP-4抑制剂治疗与COVID-19

2020-06-27

一闲 (审核中...)

前往app查看评论内容

#MET#

JNNP:抗Aβ药物治疗轻中度阿尔茨海默病的系统回顾和meta分析

2020-11-25

一闲 (审核中...)

前往app查看评论内容

#MET#

Trends Endocrinol Metab：重新思考胰岛素与癌症的关系

2020-09-20

一闲 (审核中...)

前往app查看评论内容

#MET#

日本批准CABOMETYX（cabozantinib）治疗无法切除的或转移性肾细胞癌

2020-09-29

一闲 (审核中...)

前往app查看评论内容

#MET#

Cell Metabolism：人类能否战胜糖尿病？这方面可能要向猪学学了！

2021-12-02

一闲 (审核中...)

前往app查看评论内容

#MET#

NEJM：Tepotinib治疗MET外显子14跳跃突变非小细胞肺癌II期临床效果显著

2020-09-12

一闲 (审核中...)

前往app查看评论内容

#MET#

Cell Metab :全世界都在“抗糖”，看看Cell子刊怎么说

2021-04-03

一闲 (审核中...)

前往app查看评论内容

#MET#

Diabetes Obes Metab：2型糖尿病患者肥胖与严重COVID-19结局之间的关系

2020-10-30

一闲 (审核中...)

前往app查看评论内容

#MET#

Diabetes Obes Metab：血糖控制与主要心血管事件减少之间的关系

2020-05-23

一闲 (审核中...)

前往app查看评论内容

#MET#

Metabolism：MAFLD与CKD风险

2021-04-11

一闲 (审核中...)

前往app查看评论内容

#MET#

Diabetes Obes Metab：清除慢性丙型肝炎病毒感染可降低2型糖尿病发生率

2021-03-10

一闲 (审核中...)

前往app查看评论内容

#MET#

Clin Cancer Res：转移性去势抵抗性前列腺癌c-MET和雄激素受体双重阻断:恩扎鲁胺和克唑替尼联合应用的一期研究

2021-05-19

一闲 (审核中...)

前往app查看评论内容

#MET#

Metabolism：心外膜脂肪组织与COVID-19患者肺炎严重程度和不良结局相关

2021-05-06

一闲 (审核中...)

前往app查看评论内容

#MET#

TAZVERIK（Tazemetostat）已获批准用于治疗上皮样肉瘤

2020-02-11

一闲 (审核中...)

前往app查看评论内容

#MET#

LSALT肽（Metablok）治疗COVID-19：II期临床试验将在美国进行

2020-10-06

一闲 (审核中...)

前往app查看评论内容

#MET#

Metabolism：肥胖是代谢相关脂肪肝患者发生更严重COVID-19的危险因素

2021-02-03

一闲 (审核中...)

前往app查看评论内容

#MET#

J Clin Endocrinol Metab：长期地诺单抗治疗可降低骨质疏松相关的非椎骨骨折风险

2020-09-10

科室
- - 订阅+
  - 更多科室
工具
服务